2010 OPEN FORUM Abstracts
CHANGE IN PRACTICE IMPROVES VENTILATOR ASSOCIATED PNEUMONIA IN NEONATAL PATIENTS RECEIVING AEROSOL DELIVERY.
Lindsay Hattan, Anne Polito; Respiratory Therapy, Childrens Memorial Hospital, Chicago, IL
Background: Ventilator associated pneumonia (VAP) is a concern with all patients receiving mechanical ventilation. Much has been reported on reducing risks of in the adult population, little is known in the pediatric and neonatal population, especially those receiving aerosol delivery. Method: Retrospective analysis of patients receiving mechanical ventilation and aerosol delivery from Aug 10 2009, to Jun 10, 2010 were reviewed. Criteria used to determine nosocomial infection was adapted from The Centers for Disease Control and Prevention criteria for diagnosis of ventilator associated pneumonia. In January 2010 a new more extensive VAP bundle was implemented for both RNs and RRTs and a comparison was made between the groups. All ventilated patients receiving MDI and aerosol treatments were included, with the exception of long-term trach patients. Results: 33 NICU patients met our inclusion criteria between Aug 2009 and Jun 2010 that were ventilated and receiving aerosol therapy using the Aeroneb® Pro and/ or the AeroChamber® mini during their course of ventilation. All patients were less than one year of age. From Aug 10 to Jan 10 there were 7 patients of 17 (41%) that met criteria for VAP. Following implementation of an expanded VAP bundle from Jan to June there were 4 patients of 16 (25%) that met criteria for VAP. Conclusions: The improved VAP bundle shows a favorable trend in reducing VAP in neonatal patients on mechanical ventilation and receiving aerosol delivery. Further study to include more patients is needed to establish clinical significance, and a separation of types of delivery methods will be a next step in evaluating a difference in VAP rates in this population of patients. Sponsored Research - None